期刊文献+

心钠素和甲状旁腺素对血液透析低血压的影响 被引量:1

Effect of ANF and iPTH on Hypotension During Hemodialysis
下载PDF
导出
摘要 为探讨血透患者血清心钠素 (ANF)和甲状旁腺素 (iPTH)水平与血液透析低血压的关系 ,采用放射免疫分析和免疫放射分析法分别测定 36例维持性血透患者透析前后血清ANF和iPTH水平变化 ,并分析其与低血压的关系。结果发现 :血透患者ANF和iPTH总体水平显著高于对照组 ,透析后总体水平显著低于透析前 (P均小于 0 .0 1) ;低血压组患者透析前血清ANF和iPTH水平均高于正常血压组 (P均小于 0 .0 5 ) ;透析后低血压组患者ANF水平较透析前显著降低 (P <0 .0 5 ) ,但iPTH水平较透析前进一步增高 (P <0 .0 5 )。结论 To study the effect of ANF and iPTH on hypotension during hemodialysis, the serum ANF and iPTH levels of 36 maintenance hemodialysis patients were detected by radioimmunoassay and immunoradiometricassay. Results showed that both ANF and iPTH average levels in hemodialysis patients were markedly higher than those in normal controls( P <0.01),and decreased significatly after hemodialysis( P <0.01). Before hemodialysis, both ANF and iPTH levels in hypotensive patients were signficanntly higher than those in normotensive patients( P <0.05). After hemodialysis in hypotensive patients, ANF levels decreased significantly( P <0.05), and iPTH levels increased significantly( P <0.05). Conclusions: The high serum level of ANF and iPTH might be related to hypotension during hemodialysis.
出处 《标记免疫分析与临床》 CAS 2002年第2期73-75,共3页 Labeled Immunoassays and Clinical Medicine
基金 中山医科大学附属第三医院科研基金项目(No .974 0 )
关键词 血液透析 低血压 心钠素 甲状旁腺素 放射免疫分析法 Hemodialysis Hypotension Atrial natriuretic factor Parathyroid hormone
  • 相关文献

参考文献6

  • 1[1]Heintz B, Reiners K, Gladziwa U, et al. Response of vasoactive substances to reduction of blood volume during hemodialysis in hypotensive patients[J]. Clin Nephrol,1993,39:198.
  • 2[2]de Zeeuw D, Janseen W M T.Atrial natriuretic factor: Its pathophysiologcal significance in humans[J]. Kidney Int, 1992, 41:1115.
  • 3刘冠贤,吕汉文,叶任高.慢性肾功能衰竭血浆P物质、心钠素与肾功能的关系[J].中华肾脏病杂志,1997,13(4):236-238. 被引量:6
  • 4[4]Viron B, Dussaule J C, Roger V, et al. Plasma atrial natriuretic factor and blood pressure drops during hemodialysis[J]. Nephron, 1994, 68:301.
  • 5[5]Luisetto G, Bertoli M. Sexual influence on bone metabolism in uremic patients on regular dialytic treatment[J]. Nephron, 1994;67:157.
  • 6[6]Heintz B, Mann H, Kierdof F, et al. Immunoreactive parathroid hormone after volume change in normo-and hypotensive hemodialysis patients[J]. Clin Nephrol, 1992;37:140.

二级参考文献6

  • 1陈晓春,国外医学泌尿系统分册,1996年,16卷,260页
  • 2孙志坚,中华实验和临床病毒学杂志,1995年,9卷,235页
  • 3陆孝文,肾脏内分泌学,1994年,168页
  • 4张殿明,神经内分泌学,1991年,314页
  • 5郑培良,中国药理学通报,1989年,5卷,346页
  • 6王志均,胃肠激素,1985年,507页

共引文献5

同被引文献15

  • 1何长明 张训.肾脏替代治疗学[M].上海:上海科学技术文献出版社,1999.171.
  • 2[1]Guieu R,Brunet P, Sampol J,et al. Adenosine and he modialysis in human[J]. J investing Med,2001,49(1):56~67
  • 3[2]Nishimura M,Ushiyama M, Maruyama Y, et al. Association of human hepatocyte growth factor with he modialysis hypctension[J]. Hypertens Res, 2000,23(6):581~586
  • 4[5]Urena P. Arterial hypetension in dialysis[J]. Nephrol ogic,2001,22 (3): 105
  • 5季大玺,谢红浪.血液净化技术进展[J].国外医学泌尿系统分册,1998,18(7):47.
  • 6[10]Boero R ,Pignataro A, Ferro M,et al. Sympathetic nervous system and chronic renal failure[J]. Clib Exp Hypertens,2001,23(1-2):69~75
  • 7[12]Erkan E,Devarajan P,Kaskel F. Role of nitric oxide endothelin-1, and inflammatory cytokines in blood pressure regulation in hemodialysis patients [J]. Am J kidney Dis,2002,40(1) :76~81
  • 8[15]Cases A,Esforzado N,Lario S,et al. Increased Plasma adrenormedullin levels in hemodialysis patients with sustained hypotension[J]. Kidney Int, 2000,57 (2): 664~ 670
  • 9[16]Guieu R,Brunet P,Sampol J,et al. Adenosine and hemodialysis in humans[J]. J Investing Med,2001,49(1): 56~67
  • 10林善琰.当代肾脏病学[M].上海:上海科技教育出版社,2001.814-819.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部